CARDIOME PHARMA CORP's ticker is and the CUSIP is 14159U901. A total of 1 filers reported holding CARDIOME PHARMA CORP in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $38,000 | -43.3% | 4,700 | -40.5% | 0.00% | – |
| Q3 2015 | $67,000 | -13.0% | 7,900 | -3.7% | 0.00% | – |
| Q2 2015 | $77,000 | +37.5% | 8,200 | +36.7% | 0.00% | – |
| Q1 2015 | $56,000 | -41.7% | 6,000 | -42.3% | 0.00% | – |
| Q4 2014 | $96,000 | -47.3% | 10,400 | -49.0% | 0.00% | – |
| Q3 2014 | $182,000 | +366.7% | 20,400 | +308.0% | 0.00% | – |
| Q2 2014 | $39,000 | +21.9% | 5,000 | +22.0% | 0.00% | – |
| Q1 2014 | $32,000 | +300.0% | 4,100 | +215.4% | 0.00% | – |
| Q4 2013 | $8,000 | -55.6% | 1,300 | -74.0% | 0.00% | – |
| Q3 2013 | $18,000 | -18.2% | 5,000 | -55.4% | 0.00% | – |
| Q2 2013 | $22,000 | – | 11,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Citadel Advisors | 11,200 | $22,000 | 0.00% |